|
PROSTATE, LUNG, COLO-RECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL EXPANSION F
|
N01CN075022-063
|
$1,617,215
|
$404,304
|
FOUAD, MONA
|
ALABAMA UNIV BIRMINGHAM:1109410
|
|
DNA mismatch repair and cancer in murine models
|
5R01CA076329-12
|
$390,439
|
$390,439
|
EDELMANN, WINFRIED
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
5P30CA013330-37
|
$3,927,232
|
$314,179
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Pro & Anti-Inflammatory Cytokines in Colorectal Cancer
|
5R01CA122654-02
|
$625,384
|
$625,384
|
HO, GLORIA
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Novel Methods for Molecular Analysis of Colorectal Cancer Tissue
|
2R44CA121473-02A2
|
$524,547
|
$524,547
|
Han, James
|
AMBERGEN, INC
|
|
A Novel Non-Invasive CRC Test Based on Mass Spec Of In Vitro Expressed Proteins
|
5R44CA119565-04
|
$469,320
|
$469,320
|
Han, James
|
AMBERGEN, INC
|
|
Improving colonoscopic miss rate by real time microvascular blood analysis
|
5R42CA130508-03
|
$346,336
|
$346,336
|
Roy, Hemant
|
AMERICAN BIOOPTICS, LLC
|
|
Community Clinical Oncology Program Research Base
|
3U10CA037422-22S1
|
$26,578
|
$2,658
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
5U10CA037422-22
|
$1,683,081
|
$168,308
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
American College of Radiology Imaging Network
|
5U01CA080098-11
|
$8,896,390
|
$1,112,049
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
QUALITY RESEARCH IN RADIATION ONCOLOGY: ACR PCS
|
5R01CA065435-11
|
$564,543
|
$112,909
|
WILSON, JESSE
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Storytelling to Promote Colorectal Screening in Primary Care Clinics
|
7R01CA116467-04
|
$409,128
|
$409,128
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Storytelling for Colorectal Health among Latinos
|
7R01CA118663-03
|
$520,985
|
$520,985
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Molecular Target Focused Discovery of Anticancer Drugs
|
5R01CA090441-07
|
$381,250
|
$53,375
|
PETTIT, GEORGE
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
PHASE I AND II CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
|
N01CN035158-010
|
$1,432,000
|
$143,200
|
CHOW, SHERRY
|
ARIZONA UNIV:1109859
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-20
|
$521,201
|
$67,756
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
NSABP Participating Sites
|
5U10CA118735-04
|
$67,765
|
$10,165
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Reducing Missed And Delayed Diagnoses In Cancer: Lessons From Aviation
|
5K23CA125585-03
|
$141,750
|
$46,778
|
SINGH, HARDEEP
|
BAYLOR COLLEGE OF MEDICINE
|
|
Familial and Early Onset Colorectal Cancer
|
2R01CA072851-14
|
$342,796
|
$342,796
|
BOLAND, CLEMENT
|
BAYLOR RESEARCH INSTITUTE
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-26
|
$430,954
|
$73,262
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-11
|
$130,866
|
$17,013
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
BIDMC Research Training Grant in Cancer Radiology
|
5T32CA059367-15
|
$99,433
|
$19,887
|
CLOUSE, MELVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of Fibroblasts in Cancer
|
3R01CA125550-02S1
|
|
$0
|
KALLURI, RAGHU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of Fibroblasts in Cancer
|
3R01CA125550-02S2
|
$47,638
|
$23,819
|
KALLURI, RAGHU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of Fibroblasts in Cancer
|
5R01CA125550-02
|
$255,000
|
$127,500
|
KALLURI, RAGHU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Mechanisms of Hemidesmosome Disassembly: Role of a6b4 integrin phosphorylation
|
5R01CA120202-03
|
$290,700
|
$29,070
|
RABINOVITZ, ISAAC
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Geostatistical software for the analysis of individual-level epidemiologic data
|
2R44CA132347-02
|
$426,057
|
$144,859
|
GOOVAERTS, PIERRE
|
BIOMEDWARE
|
|
Development of ADAM10 Prodomain as a Therapeutic Agent
|
1R41CA139856-01
|
$107,442
|
$26,861
|
DEMPSEY, PETER
|
BIOZYME, INC.
|
|
A Risk Prediction Model for Colorectal Cancer Screening
|
5R01CA131197-02
|
$528,903
|
$528,903
|
SCHROY, PAUL
|
BOSTON MEDICAL CENTER
|
|
Nanoscale Functional Dendrimer-DNA Assemblies
|
5R21CA125327-03
|
$162,500
|
$162,500
|
GRINSTAFF, MARK
|
BOSTON UNIVERSITY
|
|
Disparities in Lung and Colorectal Cancers
|
5R03CA130067-02
|
$81,250
|
$40,625
|
Boehmer, Ulrike
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Follow-up Study for Causes of Illness in Black Women
|
2R01CA058420-16A1
|
$1,737,319
|
$868,660
|
Rosenberg, Lynn
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Communication of Genetic and Environmental Risks in Colorectal Cancer Prevention
|
7K07CA131103-02
|
$135,027
|
$135,027
|
WANG, CATHARINE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Characterizing disease and treatment response in colon cancer chemoprevention
|
5K05CA131504-02
|
$163,042
|
$163,042
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dietary Methyl Score, Genomic DNA Methylation and Colorectal Cancer
|
1R01CA136950-01A1
|
$331,481
|
$331,481
|
CHO, EUNYOUNG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Physicians' Health Study II: Prevention Trial of Vitamins
|
5R01CA097193-08
|
$1,606,928
|
$321,386
|
GAZIANO, J
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
5P01CA087969-10
|
$4,850,916
|
$1,455,275
|
Hankinson, Susan
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Mouse Models for Human Cancer
|
2U01CA084301-11
|
$664,955
|
$664,955
|
KUCHERLAPATI, RAJU
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Sex steroid hormones, gene variants, and colorectal cancer
|
5R01CA126846-02
|
$516,142
|
$516,142
|
Lin, Jennifer
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
VITamin D and omegA-3 triaL (VITAL)
|
1U01CA138962-01
|
$2,694,337
|
$538,867
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Molecular Analysis of CD44 on Colon Cancer Cells
|
5R01CA121335-03
|
$332,500
|
$332,500
|
SACKSTEIN, ROBERT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Testing and Cancer Screening in Hereditary Cancer Syndromes
|
5K07CA120448-03
|
$141,548
|
$141,548
|
STOFFEL, ELENA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Estrogen and Progesterone-related Gene Variants and Colorectal Cancer Risk
|
5R01CA123089-04
|
$339,313
|
$339,313
|
ZHANG, SHUMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Adherence to Self-Paced vs Prescribed Intensity PA: Exploring Mechanisms via EMA
|
7R21CA137211-02
|
$228,329
|
$114,165
|
WILLIAMS, DAVID
|
BROWN UNIVERSITY
|
|
"Curaxins, Multifunctional Anticancer Agents" - Topic 255
|
N43CO900064-000
|
$148,725
|
$74,363
|
Burkhart, Catherine
|
BUFFALO BIOLABS, LLC:1166747
|
|
SIGNAL TRANSDUCTION AND CELL DEATH REGULATION
|
5P01CA069381-14
|
$1,761,940
|
$352,388
|
REED, JOHN
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
FXR signaling pathway is a valid target for chemoprevention in colorectal cancer
|
1R01CA135300-01A1
|
$571,328
|
$571,328
|
SMITH, JEFFREY
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Metalloproteinases in Tumor Progression and Metastasis
|
5R01CA108959-05
|
$516,592
|
$129,148
|
SMITH, JEFFREY
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
S100A8/A9 and carboxylated N-glycans in inflammation-mediated colon cancer
|
1R21CA127780-01A2
|
$210,100
|
$210,100
|
Srikrishna, Geetha
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
MT1-MMP pericellular proteolysis in malignancy
|
3R01CA077470-11S1
|
$47,697
|
$11,924
|
Strongin, Alex
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
Total relevant funding to Colon/Rectum for this search: $264,186,749
|